Recurrent Rectal Cancer Completed Phase 3 Trials for Eniluracil (DB03516)

Also known as: Rectal cancer recurrent / Carcinoma rectum recurrent / Rectal carcinoma recurrent / Carcinoma of rectum recurrent

IndicationStatusPhase
DBCOND0028583 (Recurrent Rectal Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003873Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal CancerTreatment